Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients ; volume:18 ; number:1 ; day:9 ; month:7 ; year:2018 ; pages:1-8 ; date:12.2018
BMC cancer ; 18, Heft 1 (9.7.2018), 1-8, 12.2018
- Urheber
-
McEvoy, Ashleigh C.
- Beteiligte Personen und Organisationen
-
Warburton, Lydia
Al-Ogaili, Zeyad
Celliers, Liesl
Calapre, Leslie
Pereira, Michelle R.
Khattak, Muhammad A.
Meniawy, Tarek M.
Millward, Michael
Ziman, Melanie
Gray, Elin S.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4637-6
- URN
-
urn:nbn:de:101:1-2018091322083210038074
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- McEvoy, Ashleigh C.
- Warburton, Lydia
- Al-Ogaili, Zeyad
- Celliers, Liesl
- Calapre, Leslie
- Pereira, Michelle R.
- Khattak, Muhammad A.
- Meniawy, Tarek M.
- Millward, Michael
- Ziman, Melanie
- Gray, Elin S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Circulating Tumour DNA in Melanoma—Clinic Ready?
Detection of metastases using circulating tumour DNA in uveal melanoma
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Biomarkers in cancer/Circulating tumour markers
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Communication between fibroblasts and tumour cells in the tumour microenvironment during melanoma progression
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma
Ex vivo expansion of circulating tumour cells (CTCs)
Circulating Tumour DNA in Melanoma—Clinic Ready?
Detection of metastases using circulating tumour DNA in uveal melanoma
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Biomarkers in cancer/Circulating tumour markers
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Communication between fibroblasts and tumour cells in the tumour microenvironment during melanoma progression
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma
Ex vivo expansion of circulating tumour cells (CTCs)
Circulating Tumour DNA in Melanoma—Clinic Ready?
Detection of metastases using circulating tumour DNA in uveal melanoma
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Biomarkers in cancer/Circulating tumour markers
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Communication between fibroblasts and tumour cells in the tumour microenvironment during melanoma progression
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma